DANAHER ($DHR) posted quarterly earnings results for Q4 2025 on Wednesday, January 28th. The company reported earnings of $2.23 per share, beating estimates of $2.17 by $0.06. The company also reported revenue of $6,838,000,000, missing estimates of $6,874,320,933 by $-36,320,933.
You can see Quiver Quantitative's $DHR stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
DANAHER Insider Trading Activity
DANAHER insiders have traded $DHR stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales.
Here’s a breakdown of recent trading of $DHR stock by insiders over the last 6 months:
- MITCHELL P RALES (Chairman of Exec. Committee) has made 0 purchases and 6 sales selling 477,625 shares for an estimated $104,925,233.
- BRIAN W ELLIS (Senior Vice President - GC) has made 0 purchases and 2 sales selling 21,776 shares for an estimated $4,773,863.
- MATTHEW MCGREW (EVP & Chief Financial Officer) sold 16,172 shares for an estimated $3,470,831
- TERI LIST has made 0 purchases and 2 sales selling 6,076 shares for an estimated $1,333,316.
- GEORGEANN COUCHARA (SVP, Human Resources) has made 0 purchases and 2 sales selling 5,174 shares for an estimated $1,088,703.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
DANAHER Hedge Fund Activity
We have seen 932 institutional investors add shares of DANAHER stock to their portfolio, and 1,052 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO added 11,254,213 shares (+152.3%) to their portfolio in Q3 2025, for an estimated $2,231,260,269
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 3,705,143 shares (+58.2%) to their portfolio in Q3 2025, for an estimated $734,581,651
- WELLINGTON MANAGEMENT GROUP LLP removed 3,517,388 shares (-20.6%) from their portfolio in Q3 2025, for an estimated $697,357,344
- CAPITAL WORLD INVESTORS removed 3,362,885 shares (-87.3%) from their portfolio in Q3 2025, for an estimated $666,725,580
- EAGLE CAPITAL MANAGEMENT LLC added 3,322,689 shares (+116.2%) to their portfolio in Q3 2025, for an estimated $658,756,321
- HOLOCENE ADVISORS, LP removed 2,450,999 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $485,935,061
- BANK OF NEW YORK MELLON CORP removed 2,362,560 shares (-28.1%) from their portfolio in Q3 2025, for an estimated $468,401,145
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
DANAHER Government Contracts
We have seen $119,752,129 of award payments to $DHR over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- POLYMERASE CHAIN REACTION (PCR) DIAGNOSTIC TESTING FOR VISN 2 DOWNSTATE: $3,781,390
- AB SCIEX SERVICE & MAINTENANCE AGREEMENT SUPPORT: $3,403,150
- IN-VITRO REAGENTS - VISN 15, ORDERING PERIOD ONE: $2,952,609
- MOLECULAR DIAGNOSTIC TESTS FOR SARS-COV-2: $2,678,865
- MICROBIOLOGY REAGENTS & CONSUMABLES ADD CLAUSE 852.222-71 - COMPLIANCE WITH EXECUTIVE ORDER 13899: $2,353,640
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
DANAHER Congressional Stock Trading
Members of Congress have traded $DHR stock 6 times in the past 6 months. Of those trades, 2 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $DHR stock by members of Congress over the last 6 months:
- REPRESENTATIVE JULIE JOHNSON has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/07 and 2 sales worth up to $30,000 on 12/18, 11/13.
- REPRESENTATIVE LISA C. MCCLAIN sold up to $15,000 on 09/25.
- REPRESENTATIVE THOMAS H. KEAN, JR. purchased up to $15,000 on 09/03.
- SENATOR SHELDON WHITEHOUSE sold up to $15,000 on 08/28.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
DANAHER Analyst Ratings
Wall Street analysts have issued reports on $DHR in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Goldman Sachs issued a "Buy" rating on 12/09/2025
- TD Cowen issued a "Buy" rating on 10/22/2025
- Barclays issued a "Overweight" rating on 10/22/2025
- Evercore ISI Group issued a "Outperform" rating on 10/07/2025
- B of A Securities issued a "Buy" rating on 09/22/2025
To track analyst ratings and price targets for DANAHER, check out Quiver Quantitative's $DHR forecast page.
DANAHER Price Targets
Multiple analysts have issued price targets for $DHR recently. We have seen 9 analysts offer price targets for $DHR in the last 6 months, with a median target of $250.0.
Here are some recent targets:
- Dan Brennan from TD Cowen set a target price of $270.0 on 01/07/2026
- Subbu Nambi from Guggenheim set a target price of $275.0 on 01/05/2026
- Brandon Couillard from Wells Fargo set a target price of $240.0 on 12/15/2025
- Evie Koslosky from Goldman Sachs set a target price of $265.0 on 12/09/2025
- Kallum Titchmarsh from Morgan Stanley set a target price of $270.0 on 12/02/2025
- Luke Sergott from Barclays set a target price of $250.0 on 10/22/2025
- Ed Ridley-Day from Rothschild & Co set a target price of $220.0 on 10/08/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
